Equity and timeliness as factors in the effectiveness of an ethical prenatal sequencing service: reflections from parents and professionals
Prenatal sequencing tests are being introduced into clinical practice in many developed countries. In part due to its greater ability to detect genetic variation, offering prenatal sequencing can present ethical challenges. Here we review ethical issues arising following the implementation of prenatal sequencing in the English National Health Service (NHS). We analysed semi structured interviews conducted with 48 parents offered prenatal sequencing and 63 health professionals involved in delivering the service to identify the ethical issues raised. Two main themes were identified: (1) Equity of access (including issues around eligibility criteria, laboratory analytical processes, awareness and education of clinicians, fear of litigation, geography, parental travel costs, and access to private healthcare), and (2) Timeliness and its impact on parental decision-making in pregnancy (in the context of the law around termination of pregnancy, decision-making in the absence of prenatal sequencing results, and the "importance" of prenatal sequencing results). Recognising both the practical and systemic ethical issues that arise out of delivering a national prenatal sequencing service is crucial. Although specific to the English context, many of the issues we identified are applicable to prenatal sequencing services more broadly. Education of health professionals and parents will help to mitigate some of these ethical issues.
Authors
- Dagmar Tapon (ORCID: https://orcid.org/0000-0003-3837-4764)
- Caroline Lafarge (ORCID: https://orcid.org/0000-0003-2148-078X)
- Holly Walton (ORCID: https://orcid.org/0000-0002-8746-059X)
- Lyn S. Chitty (ORCID: https://orcid.org/0000-0002-4857-7138)
- Kerry Leeson‐Beevers (ORCID: https://orcid.org/0000-0001-8826-5086)
- Melissa K. Hill (ORCID: https://orcid.org/0000-0003-3900-1425)
- Sarah L. Wynn (ORCID: https://orcid.org/0000-0001-6531-8181)
- Hannah McInnes‐Dean (ORCID: https://orcid.org/0000-0002-5204-0069)
- Michael Parker (ORCID: https://orcid.org/0000-0002-7054-4711)
- Rhiannon Mellis (ORCID: https://orcid.org/0000-0001-9905-0654)
- Michelle Peter (ORCID: https://orcid.org/0000-0002-4977-8708)
- Jane Fisher (ORCID: https://orcid.org/0000-0003-1318-0074)
- Morgan Daniel (ORCID: https://orcid.org/0000-0002-4455-5521)
- Sophie Peet
Institutions
- Imperial College Healthcare NHS Trust (GB)
- University of West London (GB)
- Great Ormond Street Hospital (GB)
- Great Ormond Street Hospital for Children NHS Foundation Trust (GB)
- University of Oxford (GB)
- Queen Charlotte's and Chelsea Hospital (GB)
- Institute of Child Health (IN)
- Genetic Alliance UK (United Kingdom) (GB)
- Wellcome Centre for Ethics and Humanities (GB)
- University College London (GB)
Publication Details
- Journal
- European Journal of Human Genetics
- Published
- 2024-10-03
- DOI
- https://doi.org/10.1038/s41431-024-01700-0
- Citations
- 4
- Primary Topic
- Prenatal Screening and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 4.44
Funders
- National Institute for Health and Care Research
- Great Ormond Street Institute of Child Health
- Health Services Research Programme
- Health Services and Delivery Research Programme